MPD: Phenotype measures mapped to MP:0001819, abnormal immune cell physiology

Phenotype measures associated with ontology term
MP:0001819 'abnormal immune cell physiology'

This list includes measures mapped MP:0001819 AND its ontology descendants. Alternatively, you can show measures mapped to MP:0001819 only.

MP:0002423 abnormal mast cell physiology
MP:0002451 abnormal macrophage physiology
MP:0002463 abnormal neutrophil physiology
MP:0002465 abnormal eosinophil physiology
MP:0003945 abnormal lymphocyte physiology
MP:0020171 abnormal IgA level
MP:0020173 abnormal IgE level
MP:0020174 abnormal IgG level
MP:0020175 abnormal IgG1 level
MP:0020176 abnormal IgG2a level
MP:0020177 abnormal IgG2b level
MP:0020178 abnormal IgG2c level
MP:0020179 abnormal IgG3 level
MP:0020180 abnormal IgM level

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Benavides1:1	Benavides1	genotype assessment	(none)	Gpr84 allele deletion in exon 2 (0=yes, 1=no) [designation] Gpr84 48201	inbred w/CC8	58	both	6wks		2013

Donahue7:1	Donahue7	immunoglobulin quantification	(none)	immunoglobulin A (plasma IgA) [µg/mL] IgA 41601	B6.A consomic w/par	22	both	9wks	N=8	2012

Donahue7:2	Donahue7	immunoglobulin quantification	(none)	immunoglobulin G (plasma IgG) [µg/mL] IgG 41602	B6.A consomic w/par	22	both	9wks	N=8	2012

Donahue7:3	Donahue7	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 41603	B6.A consomic w/par	22	both	9wks	N=8	2012

Donahue8:1	Donahue8	immunoglobulin quantification	(none)	immunoglobulin A (plasma IgA) [µg/mL] IgA 41701	B6.PWD consomic w/par	28	both	9wks	N=8	2011

Donahue8:2	Donahue8	immunoglobulin quantification	(none)	immunoglobulin G (plasma IgG) [µg/mL] IgG 41702	B6.PWD consomic w/par	28	both	9wks	N=8	2011

Donahue8:3	Donahue8	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 41703	B6.PWD consomic w/par	28	both	9wks	N=8	2011

Eumorphia7:1	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin M (serum IgM) [µg/mL] IgM 29601	inbred	6	both	9-12wks	N=5	2008

Eumorphia7:2	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin G3 (serum IgG3) [µg/mL] IgG3 29602	inbred	6	both	9-12wks	N=5	2008

Eumorphia7:3	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin G1 (serum IgG1) [µg/mL] IgG1 29603	inbred	6	both	9-12wks	N=5	2008

Eumorphia7:4	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin G2b (serum IgG2b) [µg/mL] IgG2b 29604	inbred	6	both	9-12wks	N=5	2008

Eumorphia7:5	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin G2a (serum IgG2a) [µg/mL] IgG2a 29605	inbred	6	both	9-12wks	N=5	2008

Eumorphia7:6	Eumorphia7	immunoglobulin quantification	(none)	immunoglobulin A (serum IgA) [µg/mL] IgA 29606	inbred	6	both	9-12wks	N=5	2008

Farmer1:29	Farmer1	hormone quantification	(none)	lgG2a antibodies against escherichia coli membrane antigens [ng/ml] IgG2aantiECM 11329	QTL population		both	6wks	N=206	2001

Farmer1:30	Farmer1	hormone quantification	(none)	levels of total lgG reactivity against escherichia coli membrane (ECM) antigens [ng/ml] IgGantiECM 11330	QTL population		both	6wks	N=206	2001

Farmer1:31	Farmer1	hormone quantification	(none)	secretory IgA in collected blood [ng/ml] IgA 11331	QTL population		both	6wks	N=206	2001

Farmer1:32	Farmer1	hormone quantification	(none)	levels of IgA secreted in feces [ng/ml] IgAfeces 11332	QTL population		both	6wks	N=206	2001

GMC20:2	GMC20	immunoglobulin quantification	(none)	immunoglobulin M (plasma IgM) [µg/mL] IgM 56902 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=6	2018

GMC20:4	GMC20	immunoglobulin quantification	(none)	immunoglobulin A (plasma IgA) [µg/mL] IgA 56904 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=5	2018

GMC20:6	GMC20	immunoglobulin quantification	(none)	immunoglobulin G1 (plasma IgG1) [µg/mL] IgG1 56906 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=4	2018

GMC20:8	GMC20	immunoglobulin quantification	(none)	immunoglobulin G2a (plasma IgG2a) [µg/mL] IgG2a 56908 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=6	2018

GMC20:10	GMC20	immunoglobulin quantification	(none)	immunoglobulin G2b (plasma IgG2b) [µg/mL] IgG2b 56910 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=4	2018

GMC20:12	GMC20	immunoglobulin quantification	(none)	immunoglobulin G3 (plasma IgG3) [µg/mL] IgG3 56912 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=6	2018

GMC20:14	GMC20	immunoglobulin quantification	(none)	immunoglobulin E (plasma IgE) [ng/mL] IgE 56914 age 16-17wks 20-21wks	inbred w/CC8	8	both		N=6	2018

Graham1:61	Graham1	immunoglobulin quantification	West Nile virus	virus-specific IgM in serum, post infection [ng/mL] WNV_IgM 63361 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Haston1:3	Haston1	bronchoalveolar lavage assessment	radiation	percentage of macrophages in bronchoalveolar lavage [%] BAL_mac 48803	inbred	26	both	15-36wks	N=6	2012

Haston1:4	Haston1	bronchoalveolar lavage assessment	radiation	percentage of lymphocytes in bronchoalveolar lavage [%] BAL_lym 48804	inbred	26	both	15-36wks	N=6	2012

Haston1:5	Haston1	bronchoalveolar lavage assessment	radiation	percentage of neutrophils in bronchoalveolar lavage [%] BAL_neut 48805	inbred	26	both	15-36wks	N=6	2012

Haston1:6	Haston1	histopathology	radiation	average number of mast cells per mm² of lung tissue [n] mast_cells 48806	inbred	25	both	15-36wks	N=6	2012

Noll1:26	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin M (serum IgM) area under curve (AUC) post-infection [AUC] IgM 112602 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=4	2020

Noll1:31	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin G1 (serum IgG1) area under curve (AUC) post-infection [AUC] IgG1 112607 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=4	2020

Noll1:36	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin G2a plus G2c (serum IgG2a pooled with IgG2c) area under curve (AUC) post-infection [AUC] IgG2ac 112612 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=4	2020

Noll1:41	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection [AUC] IgG2b 112617 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=3	2020

Noll1:46	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	immunoglobulin G3 (serum IgG3) area under curve (AUC) post-infection [AUC] IgG3 112622 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	46	f	8-12 wks	N=4	2020

Noll1:51	Noll1	immunoglobulin quantification	influenza A (H1N1) virus	total immunoglobulin G (serum IgG) area under curve (AUC) post-infection [AUC] Total_IgG 112627 post-infection: day 7 day 10 day 15 day 29 day 45	CC RIX	44	f	8-12 wks	N=3	2020

Schwartz2:1	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar eosinophils (percentage of total lavage cells), pre-challenge [%] pctEOS0 9801 pre-test: control OVA-sensitized	inbred	8	m	6-8wks	N=3	2001

Schwartz2:2	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar eosinophils (percentage of total lavage cells), 24h post-challenge [%] pctEOS24 9802 24h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:3	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar eosinophils (percentage of total lavage cells), 48h post-challenge [%] pctEOS48 9803 48h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:4	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar eosinophils (percentage of total lavage cells), 72h post-challenge [%] pctEOS72 9804 72h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:21	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), pre-challenge [%] pctLYM0 9821 pre-test: control OVA-sensitized	inbred	8	m	6-8wks	N=3	2001

Schwartz2:22	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), 24h post-challenge [%] pctLYM24 9822 24h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:23	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), 48h post-challenge [%] pctLYM48 9823 48h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:24	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), 72h post-challenge [%] pctLYM72 9824 72h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:41	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar neutrophils (percentage of total lavage cells), pre-challenge [%] pctNEUT0 9841 pre-test: control OVA-sensitized	inbred	8	m	6-8wks	N=3	2001

Schwartz2:42	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar neutrophils (percentage of total lavage cells), 24h post-challenge [%] pctNEUT24 9842 24h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:43	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar neutrophils (percentage of total lavage cells), 48h post-challenge [%] pctNEUT48 9843 48h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Schwartz2:44	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar neutrophils (percentage of total lavage cells), 72h post-challenge [%] pctNEUT72 9844 72h post: control OVA-sensitized	inbred	8	m	6-8wks	N=5	2001

Filter Table Results